did bpc 157 get banned BPC-157 – What Athletes Need to Know About Legality, Safety and Efficacy Understanding the Legal Risks of
Description
Exactly, the same as the first
Early CCK1 antagonists (e.g., loxiglumide) showed therapeutic potential for functional dyspepsia and gastroparesis (Zhang et al., 2021b)
It is not the use case being marketed to members of the public looking for faster recovery from training, or to biohackers looking for a longevity edge
-Pre- and post-test design performance on a given test is measured before and after the intervention to measure change
